These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21222121)

  • 21. The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance.
    Jiang W; Zhao S; Shen J; Guo L; Sun Y; Zhu Y; Ma Z; Zhang X; Hu Y; Xiao W; Li K; Li S; Zhou L; Huang L; Lu Z; Feng Y; Xiao J; Zhang EE; Yang L; Wan R
    Cell Death Dis; 2018 Feb; 9(2):149. PubMed ID: 29396463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of key microRNAs in pancreatic cancer development.
    Baradaran B; Shahbazi R; Khordadmehr M
    Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and metastasis of pancreatic carcinoma.
    Li TF; Liu J; Fu SJ
    Biomed Pharmacother; 2018 Aug; 104():145-150. PubMed ID: 29772434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455.
    Xu B; Gong X; Zi L; Li G; Dong S; Chen X; Li Y
    Cancer Sci; 2019 May; 110(5):1676-1685. PubMed ID: 30838724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in pancreatic malignancy: progress and promises.
    Srivastava SK; Arora S; Singh S; Bhardwaj A; Averett C; Singh AP
    Cancer Lett; 2014 Jun; 347(2):167-74. PubMed ID: 24561061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
    Liu QG; Li YJ; Yao L
    Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developments in miRNA gene signaling pathways in pancreatic cancer.
    Vorvis C; Koutsioumpa M; Iliopoulos D
    Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
    Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
    J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miR-601 as a novel regulator in the development of pancreatic cancer.
    Cao W; Jin H; Zhang L; Chen X; Qian H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):638-644. PubMed ID: 27993677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
    Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
    J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.
    Guo R; Gu J; Zhang Z; Wang Y; Gu C
    Biomed Res Int; 2017; 2017():2381482. PubMed ID: 28197410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer.
    Zang W; Wang Y; Wang T; Du Y; Chen X; Li M; Zhao G
    Mol Cancer; 2015 Feb; 14():37. PubMed ID: 25744894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
    Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
    Du Y; Liu M; Gao J; Li Z
    Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 40. MicroRNAs as potential therapeutic targets for pancreatic cancer.
    Chu X; Wei D; Liu X; Long D; Tian X; Yang Y
    Chin Med J (Engl); 2022 Jan; 135(1):4-10. PubMed ID: 34839317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.